U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis

NYSE:USPH • US90337L1089

82.47 USD
-1.08 (-1.29%)
Last: Feb 24, 2026, 11:10 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to USPH. USPH was compared to 101 industry peers in the Health Care Providers & Services industry. USPH has an average financial health and profitability rating. USPH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year USPH was profitable.
  • USPH had a positive operating cash flow in the past year.
  • USPH had positive earnings in each of the past 5 years.
  • USPH had a positive operating cash flow in each of the past 5 years.
USPH Yearly Net Income VS EBIT VS OCF VS FCFUSPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

  • With a decent Return On Assets value of 3.01%, USPH is doing good in the industry, outperforming 63.37% of the companies in the same industry.
  • The Return On Equity of USPH (7.15%) is better than 65.35% of its industry peers.
  • USPH has a Return On Invested Capital of 6.11%. This is in the better half of the industry: USPH outperforms 63.37% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for USPH is below the industry average of 8.93%.
  • The last Return On Invested Capital (6.11%) for USPH is above the 3 year average (5.78%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.01%
ROE 7.15%
ROIC 6.11%
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
USPH Yearly ROA, ROE, ROICUSPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • With a decent Profit Margin value of 4.75%, USPH is doing good in the industry, outperforming 79.21% of the companies in the same industry.
  • USPH's Profit Margin has declined in the last couple of years.
  • USPH's Operating Margin of 11.52% is amongst the best of the industry. USPH outperforms 82.18% of its industry peers.
  • In the last couple of years the Operating Margin of USPH has declined.
  • Looking at the Gross Margin, with a value of 18.80%, USPH is doing worse than 61.39% of the companies in the same industry.
  • In the last couple of years the Gross Margin of USPH has declined.
Industry RankSector Rank
OM 11.52%
PM (TTM) 4.75%
GM 18.8%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
USPH Yearly Profit, Operating, Gross MarginsUSPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), USPH is destroying value.
  • The number of shares outstanding for USPH has been increased compared to 1 year ago.
  • Compared to 5 years ago, USPH has more shares outstanding
  • USPH has a better debt/assets ratio than last year.
USPH Yearly Shares OutstandingUSPH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
USPH Yearly Total Debt VS Total AssetsUSPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 2.28 indicates that USPH is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of USPH (2.28) is comparable to the rest of the industry.
  • The Debt to FCF ratio of USPH is 2.82, which is a good value as it means it would take USPH, 2.82 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.82, USPH is in the better half of the industry, outperforming 73.27% of the companies in the same industry.
  • USPH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.30, USPH is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.82
Altman-Z 2.28
ROIC/WACC0.75
WACC8.18%
USPH Yearly LT Debt VS Equity VS FCFUSPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.20 indicates that USPH should not have too much problems paying its short term obligations.
  • USPH has a Current ratio (1.20) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.20 indicates that USPH should not have too much problems paying its short term obligations.
  • USPH's Quick ratio of 1.20 is in line compared to the rest of the industry. USPH outperforms 49.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
USPH Yearly Current Assets VS Current LiabilitesUSPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • USPH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.17%.
  • USPH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.76% yearly.
  • Looking at the last year, USPH shows a quite strong growth in Revenue. The Revenue has grown by 17.50% in the last year.
  • USPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.85% yearly.
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.49% on average over the next years. This is quite good.
  • Based on estimates for the next years, USPH will show a quite strong growth in Revenue. The Revenue will grow by 9.56% on average per year.
EPS Next Y3.85%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue Next Year16.97%
Revenue Next 2Y11.52%
Revenue Next 3Y9.56%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USPH Yearly Revenue VS EstimatesUSPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
USPH Yearly EPS VS EstimatesUSPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • USPH is valuated quite expensively with a Price/Earnings ratio of 31.72.
  • USPH's Price/Earnings is on the same level as the industry average.
  • USPH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 27.07, the valuation of USPH can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of USPH is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.75, USPH is valued at the same level.
Industry RankSector Rank
PE 31.72
Fwd PE 27.07
USPH Price Earnings VS Forward Price EarningsUSPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, USPH is valued a bit cheaper than the industry average as 64.36% of the companies are valued more expensively.
  • USPH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. USPH is cheaper than 63.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.03
EV/EBITDA 12.62
USPH Per share dataUSPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • USPH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)8.25
PEG (5Y)N/A
EPS Next 2Y8.66%
EPS Next 3Y8.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.08%, USPH has a reasonable but not impressive dividend return.
  • USPH's Dividend Yield is rather good when compared to the industry average which is at 0.49. USPH pays more dividend than 93.07% of the companies in the same industry.
  • USPH's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

  • On average, the dividend of USPH grows each year by 9.09%, which is quite nice.
  • USPH has paid a dividend for at least 10 years, which is a reliable track record.
  • USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
USPH Yearly Dividends per shareUSPH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 75.41% of the earnings are spent on dividend by USPH. This is not a sustainable payout ratio.
  • The dividend of USPH is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP75.41%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
USPH Yearly Income VS Free CF VS DividendUSPH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
USPH Dividend Payout.USPH Dividend Payout, showing the Payout Ratio.USPH Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

U.S. PHYSICAL THERAPY INC

NYSE:USPH (2/24/2026, 11:10:08 AM)

82.47

-1.08 (-1.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners107.98%
Inst Owner Change-1.69%
Ins Owners1.87%
Ins Owner Change-0.2%
Market Cap1.25B
Revenue(TTM)758.71M
Net Income(TTM)36.02M
Analysts84.62
Price Target104.04 (26.15%)
Short Float %5.96%
Short Ratio4.41
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP75.41%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.82%
Min EPS beat(2)-3.42%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.36%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.56%
EPS beat(12)4
Avg EPS beat(12)-0.7%
EPS beat(16)7
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)2.04%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-0.36%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.02%
PT rev (1m)-1.54%
PT rev (3m)-3.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 31.72
Fwd PE 27.07
P/S 1.65
P/FCF 22.03
P/OCF 18.03
P/B 2.49
P/tB N/A
EV/EBITDA 12.62
EPS(TTM)2.6
EY3.15%
EPS(NY)3.05
Fwd EY3.69%
FCF(TTM)3.74
FCFY4.54%
OCF(TTM)4.57
OCFY5.55%
SpS49.92
BVpS33.13
TBVpS-23.9
PEG (NY)8.25
PEG (5Y)N/A
Graham Number44.02
Profitability
Industry RankSector Rank
ROA 3.01%
ROE 7.15%
ROCE 8.08%
ROIC 6.11%
ROICexc 6.29%
ROICexgc 36.03%
OM 11.52%
PM (TTM) 4.75%
GM 18.8%
FCFM 7.5%
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexgc growth 3Y-11.04%
ROICexgc growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.82
Debt/EBITDA 1.37
Cap/Depr 53.9%
Cap/Sales 1.67%
Interest Coverage 9.84
Cash Conversion 62.74%
Profit Quality 157.98%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 2.28
F-Score6
WACC8.18%
ROIC/WACC0.75
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
EPS Next Y3.85%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
Revenue Next Year16.97%
Revenue Next 2Y11.52%
Revenue Next 3Y9.56%
Revenue Next 5YN/A
EBIT growth 1Y26.14%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year40.26%
EBIT Next 3Y18.33%
EBIT Next 5YN/A
FCF growth 1Y-11.66%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y-4.01%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%

U.S. PHYSICAL THERAPY INC / USPH FAQ

What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to USPH.


What is the valuation status for USPH stock?

ChartMill assigns a valuation rating of 3 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Overvalued.


What is the profitability of USPH stock?

U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 6 / 10.


What are the PE and PB ratios of U.S. PHYSICAL THERAPY INC (USPH) stock?

The Price/Earnings (PE) ratio for U.S. PHYSICAL THERAPY INC (USPH) is 31.72 and the Price/Book (PB) ratio is 2.49.


Is the dividend of U.S. PHYSICAL THERAPY INC sustainable?

The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 75.41%.